Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Amortization of Deferred Charges (2019 - 2021)

Anika Therapeutics (ANIK) has disclosed Amortization of Deferred Charges for 3 consecutive years, with $400000.0 as the latest value for Q3 2021.

  • Quarterly Amortization of Deferred Charges fell 2.68% to $400000.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Sep 2021, up 18.95% year-over-year, with the annual reading at $1.5 million for FY2020, 29.86% up from the prior year.
  • Amortization of Deferred Charges for Q3 2021 was $400000.0 at Anika Therapeutics, down from $507000.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $507000.0 in Q2 2021, with the low at $289000.0 in Q3 2019.
  • Average Amortization of Deferred Charges over 3 years is $365636.4, with a median of $385000.0 recorded in 2020.
  • The sharpest move saw Amortization of Deferred Charges surged 42.21% in 2020, then dropped 2.68% in 2021.
  • Over 3 years, Amortization of Deferred Charges stood at $299000.0 in 2019, then skyrocketed by 32.11% to $395000.0 in 2020, then rose by 1.27% to $400000.0 in 2021.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods came in at $400000.0, $507000.0, and $405000.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.